Efficacy Comparison Between Kegel Exercises and Extracorporeal Magnetic Innervation in Treatment of Female Stress Urinary Incontinence: A Randomized Clinical Trial
Overview
Authors
Affiliations
Background and Objectives: To estimate the effectiveness of Kegel exercises versus extracorporeal magnetic innervation (EMI) in the treatment of stress urinary incontinence (SUI). Materials and Methods: A parallel group, randomized clinical trial was conducted in the Department of Obstetrics and Gynecology, Clinical Hospital Centre Zagreb, Croatia. After assessing the inclusion/exclusion criteria, each eligible participant was randomized to one of the two observed groups by flipping a coin: the first group underwent treatment with Kegel exercises for 8 weeks, while the second group underwent EMI during the same time interval. The primary outcome was the effectiveness of treatment as measured by the ICIQ-UI-SF overall score, eight weeks after the commencement of treatment. Results: During the study period, 117 consecutive patients with SUI symptoms were assessed for eligibility. A total of 94 women constituted the study population, randomized into two groups: Group Kegel (N = 48) and Group EMI (N = 46). After 8 weeks of follow-up, intravaginal pressure values in the EMI group were 30.45 cmH2O vs. the Kegel group, whose values were 23.50 cmH2O (p = 0.001). After 3 months of follow-up, the difference was still observed between the groups (p = 0.001). After the end of treatment and 3 months of follow-up, the values of the ICIQ-UI SF and ICIQ-LUTSqol questionnaires in the EMI group were lower than in the Kegel group (p < 0.001). Treatment satisfaction was overall better in the EMI group than in the Kegel group (p < 0.001). Conclusions: Patients treated with EMI had a lower number of incontinence episodes, a better quality of life, and higher overall satisfaction with treatment than patients who performed Kegel exercises.
Li M, Qiu K, Guo H, Fan M, Yan L Front Med (Lausanne). 2024; 11:1517962.
PMID: 39703522 PMC: 11656316. DOI: 10.3389/fmed.2024.1517962.
Kolczewski P, Lukaszuk M, Cymbaluk-Ploska A, Kozlowski M, Ciecwiez S, Kuzlik R Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794192 PMC: 11125844. DOI: 10.3390/ph17050622.
The effect of duloxetine on stress urinary incontinence.
Lorzadeh N, Jahanshahi M Health Sci Rep. 2024; 7(5):e2091.
PMID: 38736475 PMC: 11082090. DOI: 10.1002/hsr2.2091.
Yang X, Zhang A, Zhu R, Sayer L, Bassett S, Woodward S Pilot Feasibility Stud. 2023; 9(1):180.
PMID: 37907990 PMC: 10617193. DOI: 10.1186/s40814-023-01410-2.
Strojek K, Straczynska A, Radziminska A, Weber-Rajek M J Clin Med. 2023; 12(17).
PMID: 37685522 PMC: 10487770. DOI: 10.3390/jcm12175455.